Thrombosis Journal

Papers
(The TQCC of Thrombosis Journal is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis63
Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta‐analysis53
Coagulation abnormalities in SARS-CoV-2 infection: overexpression tissue factor44
Warfarin versus direct oral anticoagulants for treating left ventricular thrombus: a systematic review and meta-analysis41
Tranexamic acid for the prevention and treatment of bleeding in surgery, trauma and bleeding disorders: a narrative review38
Thrombosis in COVID-19 infection: Role of platelet activation-mediated immunity37
Proximal deep vein thrombosis and pulmonary embolism in COVID-19 patients: a systematic review and meta-analysis30
Viscoelastometry for detecting oral anticoagulants25
Current status of treatment of cancer-associated venous thromboembolism24
NETosis and SARS-COV-2 infection related thrombosis: a narrative review24
Possible involvement of Syndecan-1 in the state of COVID-19 related to endothelial injury24
Fatal pulmonary arterial thrombosis in a COVID-19 patient, with asymptomatic history, occurred after swab negativization24
Complement C5a induces the generation of neutrophil extracellular traps by inhibiting mitochondrial STAT3 to promote the development of arterial thrombosis23
Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-1921
High rate of bleeding and arterial thrombosis in COVID-19: Saudi multicenter study20
Pathological findings in rotation thromboelastometry associated with thromboembolic events in COVID-19 patients18
Detailed histological analysis of a thrombectomy-resistant ischemic stroke thrombus: a case report17
Current and future strategies to monitor and manage coagulation in ECMO patients17
Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and meta-analysis of randomized controlled trials17
Evaluation of clinical outcomes in patients treated with heparin or direct thrombin inhibitors during extracorporeal membrane oxygenation: a systematic review and meta-analysis16
Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia16
Safety and efficacy of endovascular thrombectomy in acute ischemic stroke treated with anticoagulants: a systematic review and meta-analysis15
Serial markers of coagulation and inflammation and the occurrence of clinical pulmonary thromboembolism in mechanically ventilated patients with SARS-CoV-2 infection; the prospective Maastricht intens15
Coagulation dysfunction events associated with tigecycline: a real-world study from FDA adverse event reporting system (FAERS) database15
Patients with venous thromboembolism after spontaneous intracerebral hemorrhage: a review15
Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis14
Predictors of long-term post-thrombotic syndrome following high proximal deep vein thrombosis: a cross-sectional study14
Incidence of peripheral intravenous catheter phlebitis and its associated factors among patients admitted to University of Gondar hospital, Northwest Ethiopia: a prospective, observational study14
Maternal mortality following thromboembolism; incidences and prophylaxis strategies13
A review of thromboembolic events in hospitalized COVID-19 patients13
D-dimer for risk stratification and antithrombotic treatment management in acute coronary syndrome patients: a systematic review and metanalysis13
Point-of-care detection and differentiation of anticoagulant therapy - development of thromboelastometry-guided decision-making support algorithms13
Suspected heparin-induced thrombocytopenia in a COVID-19 patient on extracorporeal membrane oxygenation support: a case report13
Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India12
ADAMTS13 activity decreases in the early phase of trauma associated with coagulopathy and systemic inflammation: a prospective observational study12
Endovascular revascularization strategies using catheter-based thrombectomy versus conventional catheter-directed thrombolysis for acute limb ischemia11
Peripherally inserted central venous catheter in upper extremities leads to an increase in D-dimer and deep vein thrombosis in lower extremities11
Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data11
Clinical significance of D-dimer levels during acute period in ischemic stroke11
Clinical significance of neutrophil extracellular traps biomarkers in thrombosis11
Safety, efficacy and prognosis of anticoagulant therapy for portal vein thrombosis in cirrhosis: a retrospective cohort study11
Impact of oral anticoagulation therapy on postoperative atrial fibrillation outcomes: a systematic review and meta-analysis11
Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism11
Autopsy and statistical evidence of disturbed hemostasis progress in COVID-19: medical records from 407 patients11
Frequency of deep vein thrombosis at admission for acute stroke and associated factors: a cross-sectional study11
Point of care diagnostic of hypercoagulability and platelet function in COVID-19 induced acute respiratory distress syndrome: a retrospective observational study11
Von Willebrand factor:antigen and ADAMTS-13 level, but not soluble P-selectin, are risk factors for the first asymptomatic deep vein thrombosis in cancer patients undergoing chemotherapy10
Incidence, risk factors, and clinical impact of major bleeding in hospitalized patients with COVID-19: a sub-analysis of the CLOT-COVID Study10
Incidence and characteristics of arterial thromboemboli in patients with COVID-1910
Risk factors of thrombosis in Chinese subjects with acute promyelocytic leukemia10
Review article inferior vena cava thrombosis: a case series of patients observed in Taiwan and literature review10
Thrombin generation capacity is enhanced by low antithrombin activity and depends on the activity of the related coagulation factors10
Prognostic Value of D-dimer in patients with acute coronary syndrome treated by percutaneous coronary intervention: a retrospective cohort study10
Lupus anticoagulant hypoprothrombinemia syndrome associated with bilateral adrenal haemorrhage in a child: early diagnosis and intervention10
Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis10
Hypofibrinogenemia is associated with a high degree of risk in infectious diseases: a post-hoc analysis of post-marketing surveillance of patients with disseminated intravascular coagulation treated w10
Malignant tumor is the greatest risk factor for pulmonary embolism in hospitalized patients: a single-center study9
Optimal authoritative risk assessment score of Cancer-associated venous thromboembolism for hospitalized medical patients with lung Cancer9
Immune activation and inflammatory biomarkers as predictors of venous thromboembolism in lymphoma patients9
Tranexamic acid for haemostasis and beyond: does dose matter?9
Calibrated automated thrombogram II: removing barriers for thrombin generation measurements9
Platelet adhesion in type 2 diabetes: impact of plasma albumin and mean platelet volume9
Direct oral anticoagulants versus low-molecular-weight heparins for the treatment of acute venous thromboembolism in patients with gastrointestinal cancer: a systematic review and meta-analysis9
Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study9
The impact on renal function after long-term use of anticoagulants in atrial fibrillation patients8
Identification and characterization of two SERPINC1 mutations causing congenital antithrombin deficiency8
Comparison of deep vein thrombosis risks in acute respiratory distress syndrome caused by COVID-19 and bacterial pneumonia: a retrospective cohort study8
Differential effect of statin use on coagulation markers: an active comparative analysis in the NEO study8
Use of laboratory testing for prediction of postoperative bleeding volume in cardiovascular surgery8
Low incidence of venous thrombosis but high incidence of arterial thrombotic complications among critically ill COVID-19 patients in Singapore8
Successful venous thromboprophylaxis in a patient with vaccine-induced immune thrombotic thrombocytopenia (VITT): a case report of the first reported case in Thailand8
Low FXIII activity levels in intensive care unit hospitalized COVID-19 patients8
Efficacy and safety of rivaroxaban for the treatment of PICC-related upper extremity deep vein thrombosis in cancer patients: a retrospective study8
Histopathologically TMA-like distribution of multiple organ thromboses following the initial dose of the BNT162b2 mRNA vaccine (Comirnaty, Pfizer/BioNTech): an autopsy case report7
Correction to: Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis7
Long noncoding RNA TUG1 induces angiogenesis of endothelial progenitor cells and dissolution of deep vein thrombosis7
The trends in the incidence and thrombosis-related comorbidities of antiphospholipid syndrome: a 14-year nationwide population-based study7
Agitation-dependent biomechanical forces modulate GPVI receptor expression and platelet adhesion capacity during storage7
Association between inflammatory biomarkers and venous thromboembolism: a systematic review and meta-analysis7
Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis7
Association of circulating proprotein convertase subtilisin/kexin type 9 concentration, prothrombin time and cardiovascular outcomes: a prospective cohort study7
LINC00659 exacerbates endothelial progenitor cell dysfunction in deep vein thrombosis of the lower extremities by activating DNMT3A-mediated FGF1 promoter methylation7
Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia7
Platelet indices and blood pressure: a multivariable mendelian randomization study6
Comparison of anticoagulated versus non-anticoagulated patients with intra-aortic balloon pumps6
Unprovoked internal jugular vein thrombosis: a case report and literature review6
The use of direct oral anticoagulants for thromboprophylaxis or treatment of cancer-associated venous thromboembolism: a meta-analysis and review of the guidelines6
JAK2V617F positive polycythemia vera with paroxysmal nocturnal hemoglobinuria and visceral thromboses: a case report and review of the literature6
Point of care ultrasound screening for deep vein thrombosis in critically ill COVID-19 patients, an observational study6
The evolution of clot strength in critically-ill COVID-19 patients: a prospective observational thromboelastography study6
Anticoagulation may contribute to antimicrobial treatment of Lemierre syndrome: a case report6
Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE6
Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study6
A novel prognostic prediction indicator in patients with acute pulmonary embolism: Naples prognostic score6
Experience of danaparoid to treat vaccine-induced immune thrombocytopenia and thrombosis, VITT6
Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications6
Evaluation of Apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort study5
An evaluation of venous thromboembolism by whole-body enhanced CT scan for critical COVID-19 pneumonia with markedly rises of coagulopathy related factors: a case series study5
The role of Sphingomyelin synthase 2 (SMS2) in platelet activation and its clinical significance5
Circulating LPS from gut microbiota leverages stenosis-induced deep vein thrombosis in mice5
The efficacy of tranexamic acid treatment with different time and doses for traumatic brain injury: a systematic review and meta-analysis5
High prevalence of thrombophilic risk factors in patients with central retinal artery occlusion5
Association between cardiovascular risk-factors and venous thromboembolism in a large longitudinal study of French women5
Structure, signal transduction, activation, and inhibition of integrin αIIbβ35
The effect of neutrophil extracellular traps in venous thrombosis5
Feasibility of anticoagulation using low molecular-weight heparin during catheter-directed thrombolysis for lower extremity deep venous thrombosis5
The association between ROS1 rearrangement and risk of thromboembolic events in patients with advanced non-small cell lung cancer: a multicenter study in China5
Giant intracardiac thrombosis in an infant with leukaemia and prolonged COVID-19 viral RNA shedding: a case report5
Risk factors for central venous catheter-associated deep venous thrombosis in pediatric critical care settings identified by fusion model5
Coagulopathy and its associated factors among patients with a bleeding diathesis at the University of Gondar Specialized Referral Hospital, Northwest Ethiopia5
Prediction of residual ischemic risk in ticagrelor-treated patients with acute coronary syndrome5
Cardiovascular risk factors are associated with augmented thrombogenicity in healthy individuals: analysis using the Total Thrombus-formation Analysis System5
Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-195
Narsoplimab for severe transplant-associated thrombotic microangiopathy5
Lead thrombus under standard-dose edoxaban in a patient with normal to high creatinine clearance and protein S deficiency5
0.038532972335815